Mira Pharmaceuticals Inc (MIRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2800 +0.0600 (+4.92%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2600 -0.0200 (-1.56%) 18:54 ET
for Fri, Mar 21st, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | |
| Operating Expenses | 8,526 | 7,048 |
| Operating Income | -8,526 | -7,048 |
| Interest Expense | 3,456 | 10 |
| Pre-tax Income | -11,982 | -7,058 |
| Net Income Continuous | -11,982 | -7,058 |
| Net Income | $-11,982 | $-7,058 |
| EPS Basic Total Ops | -0.64 | -0.40 |
| EPS Basic Continuous Ops | -0.65 | -0.40 |
| EPS Diluted Total Ops | -0.64 | -0.40 |
| EPS Diluted Continuous Ops | -0.65 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.64 | N/A |
| EBITDA(a) | $-7,794 | $-7,048 |